Citadel Advisors
CELL

Citadel Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Citadel Advisors’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,000
Closed -$4.41K – 15459
2023
Q2 		$4.41K Sell
9,000
-12,400
-58% -$10.1K ﹤0.01% 13600
2023
Q1 		$24.8K Sell
21,400
-5,300
-20% -$9.69K ﹤0.01% 12897
2022
Q4 		$71.6K Buy
26,700
+7,700
+41% +$20.3K ﹤0.01% 11678
2022
Q3 		$54K Sell
19,000
-6,100
-24% -$25.9K ﹤0.01% 11576
2022
Q2 		$125K Sell
25,100
-16,000
-39% -$83.8K ﹤0.01% 11173
2022
Q1 		$292K Buy
41,100
+3,100
+8% +$25.6K ﹤0.01% 10657
2021
Q4 		$691K Sell
38,000
-46,400
-55% -$1M ﹤0.01% 8877
2021
Q3 		$1.65M Buy
84,400
+48,800
+137% +$1.86M ﹤0.01% 6849
2021
Q2 		$1.59M Buy
35,600
+10,900
+44% +$505K ﹤0.01% 7163
2021
Q1 		$1.24M Buy
24,700
+10,400
+73% +$709K ﹤0.01% 7563
2020
Q4 		$1.28M Buy
+14,300
New +$1.2M ﹤0.01% 6266

Other funds holding CELL

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors's CELL Position: Q2 2023 in Review

Citadel Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 67,104 shares — an estimated $54.9K sold.

Citadel Advisors first reported a position in CELL in Q3 2020 and held it in 11 quarters. The position peaked at $12M in Q1 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Citadel Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 67,104 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $54.9K.
  • Citadel Advisors first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Citadel Advisors's PhenomeX Inc. Common Stock position peaked at $12M in Q1 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.